Telik
Biopharmaceutical company focused on developing drugs for cancer and inflammatory diseases
Last updated November 4, 2026
AI crawler reads
3requests
1companies- Anthropic3
- Profile
- 3
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Telik was a defunct biopharmaceutical company that developed innovative drugs for cancer and inflammatory diseases. Its most notable candidate was Telcyta (canfosfamide), but clinical trials failed to meet expectations, leading to bankruptcy.
Products and positioning
A biopharmaceutical company focused on oncology and inflammation
Cite this profile: Cite the canonical profile. /brand-wiki/telik · Editorial policy · How profiles are compiled